Ramzi Ajjan

16.5k total citations · 2 hit papers
232 papers, 7.4k citations indexed

About

Ramzi Ajjan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ramzi Ajjan has authored 232 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Endocrinology, Diabetes and Metabolism, 53 papers in Surgery and 48 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ramzi Ajjan's work include Diabetes Management and Research (70 papers), Diabetes Treatment and Management (48 papers) and Blood properties and coagulation (40 papers). Ramzi Ajjan is often cited by papers focused on Diabetes Management and Research (70 papers), Diabetes Treatment and Management (48 papers) and Blood properties and coagulation (40 papers). Ramzi Ajjan collaborates with scholars based in United Kingdom, United States and Germany. Ramzi Ajjan's co-authors include Anthony P. Weetman, Peter J. Grant, Gerry Rayman, Jean‐Pierre Riveline, H. Hanaire, Norbert Hermanns, Thomas Haak, P. F. Watson, Robert F. Storey and Timothy C. Dunn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Ramzi Ajjan

220 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

2016 441 citations Ramzi Ajjan et al. profile →
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

2022 163 citations Robert F. Storey, Ramzi Ajjan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ramzi Ajjan United Kingdom	49	3.4k	1.6k	1.4k	1.4k	944	232	7.4k
Günter Wolf Germany	52	2.3k 0.7×	1.4k 0.9×	1.9k 1.4×	768 0.6×	1.1k 1.2×	359	12.3k
Joseph P. McConnell United States	42	1.4k 0.4×	3.0k 1.9×	2.0k 1.5×	699 0.5×	583 0.6×	109	7.9k
Judith Hsia United States	48	4.6k 1.4×	2.8k 1.8×	3.5k 2.5×	3.2k 2.4×	771 0.8×	150	11.9k
Barry I. Freedman United States	65	3.2k 0.9×	1.8k 1.1×	2.6k 1.9×	3.0k 2.3×	1.3k 1.3×	420	16.3k
J.J. Emeis Netherlands	42	1.7k 0.5×	1.5k 1.0×	1.6k 1.1×	587 0.4×	802 0.8×	112	7.4k
Hiromichi Suzuki Japan	43	2.1k 0.6×	1.1k 0.7×	2.9k 2.1×	715 0.5×	906 1.0×	408	8.5k
Berthold Hocher Germany	53	1.6k 0.5×	1.1k 0.7×	2.0k 1.4×	576 0.4×	1.2k 1.2×	355	9.4k
Marianne Benn Denmark	43	3.3k 1.0×	4.1k 2.6×	2.6k 1.9×	813 0.6×	435 0.5×	121	8.6k
Panagiotis Anagnostis Greece	47	2.4k 0.7×	1.6k 1.0×	672 0.5×	580 0.4×	436 0.5×	211	6.8k
Aruna D. Pradhan United States	42	2.9k 0.9×	2.5k 1.6×	2.4k 1.7×	786 0.6×	614 0.7×	88	10.0k

Countries citing papers authored by Ramzi Ajjan

Since Specialization

Citations

This map shows the geographic impact of Ramzi Ajjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi Ajjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi Ajjan more than expected).

Fields of papers citing papers by Ramzi Ajjan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramzi Ajjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi Ajjan. The network helps show where Ramzi Ajjan may publish in the future.

Co-authorship network of co-authors of Ramzi Ajjan

This figure shows the co-authorship network connecting the top 25 collaborators of Ramzi Ajjan. A scholar is included among the top collaborators of Ramzi Ajjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramzi Ajjan. Ramzi Ajjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murray, Robert, et al.. (2025). Diabetes Risk After Treatment for Childhood and Young Adult Cancer. Diabetes Care. 48(4). 519–527.

Ajjan, Ramzi, Thomas M. Barber, Sunil Bhandari, et al.. (2025). Pineal gland senescence: an emerging ageing-related pathology?. HORMONES. 25(1). 323–331.

Hopkins, Mark, Paddy C. Dempsey, Sam Pearson, et al.. (2024). Short, frequent, light‐intensity walking activity improves postprandial vascular‐inflammatory biomarkers in people with type 1 diabetes: The SIT‐LESS randomized controlled trial. Diabetes Obesity and Metabolism. 26(6). 2439–2445. 1 indexed citations

Giannoudi, Marilena, Michael Drozd, Nadira Yuldasheva, et al.. (2024). The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure. Cardiovascular Research. 120(15). 1898–1906. 3 indexed citations

Drozd, Michael, Marilena Giannoudi, John Gierula, et al.. (2023). Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study. Diabetes Care. 46(8). 1531–1540. 41 indexed citations

Ajjan, Ramzi, E. Hensor, Francesco Del Galdo, et al.. (2022). Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomised controlled trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 15 indexed citations

Speight, Jane, Pratik Choudhary, Emma G. Wilmot, et al.. (2022). Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review. Diabetic Medicine. 40(1). e14944–e14944. 40 indexed citations

Gauer, Julia S., Ramzi Ajjan, & Robert A.S. Ariëns. (2022). Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches. Journal of the American Heart Association. 11(20). e027071–e027071. 14 indexed citations

McPherson, Helen R., Cédric Duval, Stephen R. Baker, et al.. (2021). Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis. eLife. 10. 21 indexed citations

10.

Duval, Cédric, Majid Ali, Nadira Yuldasheva, et al.. (2021). Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi. Proceedings of the National Academy of Sciences. 118(27). 20 indexed citations

11.

Grant, Peter J., et al.. (2020). Diabetes and atherothrombosis: The circadian rhythm and role of melatonin in vascular protection. Diabetes and Vascular Disease Research. 17(3). 2033385114–2033385114. 25 indexed citations

12.

Everett, Colin, Catherine Reynolds, Catherine Fernandez, et al.. (2020). Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction. Diabetes and Vascular Disease Research. 17(5). 3154019310–3154019310. 2 indexed citations

13.

Ajjan, Ramzi, et al.. (2019). Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Advances in Therapy. 36(3). 579–596. 71 indexed citations

14.

Smith, Robert, Lu Han, Shehzad Ali, et al.. (2019). Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness. Journal of Psychiatric and Mental Health Nursing. 26(9-10). 347–357. 12 indexed citations

15.

Swoboda, Peter, Adam K McDiarmid, Bara Erhayiem, et al.. (2017). Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure. Journal of the American Heart Association. 6(7). 70 indexed citations

16.

Taylor, Jo, Brendon Stubbs, Catherine Hewitt, et al.. (2017). The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis. PLoS ONE. 12(1). e0168549–e0168549. 35 indexed citations

17.

Christiansen, Morten Krogh, Sanne Bøjet Larsen, Mette Nyegaard, et al.. (2017). Coronary artery disease-associated genetic variants and biomarkers of inflammation. PLoS ONE. 12(7). e0180365–e0180365. 27 indexed citations

18.

Gault, Victor A., Christian Hölscher, Peter R. Flatt, et al.. (2013). Cell signalling and diabetes. Diabetic Medicine. 30(s1). 4–5. 1 indexed citations

19.

Heß, Katharina, Mathew Mathai, Kristina F. Standeven, et al.. (2009). Abstract 4940: Inflammatory Thrombotic Interactions in Young Type 1 Diabetes Subjects: Effects of Glycaemic Control. Circulation. 120(suppl_18). 1 indexed citations

20.

Ajjan, Ramzi, Nor Azmi Kamaruddin, M. Crisp, et al.. (1998). Regulation and tissue distribution of the human sodium iodide symporter gene. Clinical Endocrinology. 49(4). 517–523. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact